FDA Approved: GEMCITABINE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira, Inc.'s supplemental application for gemcitabine under ANDA 079183. This represents approval of a supplemental submission for the generic g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Bladder Cancer
• Breast Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

SUPPL AP for GEMCITABINE (GEMCITABINE)